Sreejith G. Nair

Thiruvananthapuram, KL, IN 
Clinical Trials:Currently Recruiting for 1 Trial
Thiruvananthapuram, KL, IN 

Overview

Sreejith Nair practices in Thiruvananthapuram, India. Their top areas of expertise are Plasmacytoma, Adult Soft Tissue Sarcoma, Desmoplastic Small Round Cell Tumor, and Epidural Abscess.

Their clinical research consists of co-authoring 26 peer reviewed articles and participating in 2 clinical trials. MediFind looks at clinical research from the past 15 years.

Locations

Thiruvananthapuram, KL, India

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

A Phase 2b Open-label Study of Selinexor (KPT-330) in Patients With Relapsed/Refractory Diffuse Large B-Cell Lymphoma (DLBCL)
A Phase 2b Open-label Study of Selinexor (KPT-330) in Patients With Relapsed/Refractory Diffuse Large B-Cell Lymphoma (DLBCL)
Enrollment Status: Recruiting
Publish Date: October 01, 2025
Intervention Type: Drug
Study Drug: Selinexor
Study Phase: Phase 2
A Phase 3 Randomized, Controlled, Open-label Study of Selinexor, Bortezomib, and Dexamethasone (SVd) Versus Bortezomib and Dexamethasone (Vd) in Patients With Relapsed or Refractory Multiple Myeloma (RRMM)
A Phase 3 Randomized, Controlled, Open-label Study of Selinexor, Bortezomib, and Dexamethasone (SVd) Versus Bortezomib and Dexamethasone (Vd) in Patients With Relapsed or Refractory Multiple Myeloma (RRMM)
Enrollment Status: Completed
Publish Date: August 21, 2024
Intervention Type: Drug
Study Drugs: Selinexor, Bortezomib, Dexamethasone
Study Phase: Phase 3
View 1 Less Clinical Trial

26 Total Publications

Management and survival outcomes of desmoplastic small round cell tumor: a retrospective cohort study from a tertiary cancer center.
Management and survival outcomes of desmoplastic small round cell tumor: a retrospective cohort study from a tertiary cancer center.
Journal: BMC cancer
Published: September 05, 2025

Frequently Asked Questions about Sreejith G. Nair

Is Sreejith G. Nair a top-rated expert for Plasmacytoma?

MediFind is an objective health platform that identifies experts based on real-world data. Sreejith G. Nair is classified as an Experienced expert for Plasmacytoma, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Sreejith G. Nair participate in research or clinical trials?

Yes. Sreejith G. Nair has published 26 articles and abstracts on conditions like Plasmacytoma. You can view a list of Sreejith G. Nair's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Nair's expertise for a condition
ConditionClose
        View All 18 Experienced Conditions
        Want to save this expert for later?
        Sign Up
        Not sure about your diagnosis?
        Check Your Symptoms
         
         
         
         
        Learn about our expert tiers
        Learn More
        Are you the provider on this profile?
        Claim Profile